webinar register page

Webinar banner
May 21 Expert Series - Ultragenyx’s LC-FAOD Odyssey Study: From Patient Experience to Patient Empowerment
Join MitoAction, Eliza Kruger and Kristin Voorhees from Ultragenyx on Friday, May 21, 2021 for our monthly expert series presentation!

May 21, 2021 12:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Eliza Kruger
Director of Global Health Economics & Outcomes Research @Ultragenyx
Eliza Kruger is a Director of Global Health Economics and Outcomes Research (HEOR) at Ultragenyx and an expert in HEOR. She is passionate about supporting better, evidence-based decision-making in healthcare, particularly in rare diseases. She has 10 years of experience in academia, consulting and pharmaceutical industry in Singapore and the United States. She is originally from Australia, where she completed her undergraduate in Economics and Master of Health Economics.
Kristin Voorhees
Associate Director of Patient Advocacy @Ultragenyx
Kristin Voorhees is an Associate Director of Patient Advocacy at Ultragenyx Pharmaceutical where she has the honor of representing the experiences of rare disease communities and helping to integrate the perspectives of patient and families into company and program decision-making. Kristin has more than 10 years of experience in spearheading patient engagement and patient-focused programs in close collaboration with patients, caregivers, clinicians, researchers, and the biopharmaceutical and diagnostics industries. Kristin holds a BA in Communication Studies from James Madison University and a Master of Health Communication from Emerson College and Tufts School of Medicine.